Ann
Intern Med 1994 Dec 15;121(12):953-9
The chronic fatigue syndrome:
a comprehensive approach to its definition and study. International
Chronic Fatigue Syndrome Study Group.
Fukuda
K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. and the
International Chronic Fatigue Syndrome Study Group (for a listing
of members of the Study group, see appendix)
Division
of Viral and Rickettsial Diseases, National Center for Infectious
Diseases, Centers for Disease Control and Prevention, Atlanta, GA
30333.
The
complexities of the chronic fatigue syndrome and the methodologic
problems associated with its study indicate the need for a comprehensive,
systematic, and integrated approach to the evaluation, classification,
and study of persons with this condition and other fatiguing illnesses.
We propose a conceptual framework and a set of guidelines that provide
such an approach. Our guidelines include recommendations for the
clinical evaluation of fatigued persons, a revised case definition
of the chronic fatigue syndrome, and a strategy for subgrouping
fatigued persons in formal investigations.
PMID: 7978722 [PubMed - indexed for MEDLINE]
Appendix:
The following are the other members of the International Chronic
Fatigue Syndrome Study Group:
National Institutes of Health, Bethesda, Maryland:
Ann Schluederberg, ScD; University of Colorado, Denver, Colorado:
James F. Jones, MD; Prince Henry Hospital and University of New
South Wales, Sydney, Australia: Andrew R. Lloyd, MD, FRACP; King's
College School of Medicine and Dentistry, London, United Kingdom:
Simon Wessely, MRCP, MRC Psych; Polyclinic Medical Center and Pennsylvania
State College of Medicine, Harrisburg, Pennsylvania: Nelson M. Gantz,
MD; Texas A & M University Health Science Center and Scott &
White Memorial Hospital, Temple, Texas: Gary P. Holmes, MD; University
of Washington Medical Center, Seattle, Washington: Dedra Buchwald,
MD; University of Toronto, Toronto, Canada: Susan Abbey, MD, FRCP(C);
University of California, San Francisco, San Francisco, California,
and Alta Bates Hospital, Berkeley, California: Jonathan Rest, MD;
University of California, San Francisco, San Francisco, California:
Jay A. Levy, MD; Food and Drug Administration, Rockville, Maryland:
Heidi Jolson, MD, MPH; Lake Tahoe Medical Center, Incline Village,
Nevada: Daniel L. Peterson, MD; University Hospital Nijmegen, Nijmegen,
the Netherlands: Jan H.M.M. Vercoulen, PhD; Centro Regionale di
Riferminento Oncologico, Aviano, Italy: Umberto Tirelli, MD; Karolinska
Institute at Huddinge University Hospital, Stockholm, Sweden: Birgitta
Even- gard, MD; New Jersey Medical School, Newark, New Jersey: Benjamin
H. Natelson, MD; Centers for Disease Control and Prevention, Atlanta,
Georgia: Lea Steele, Michele Reyes, and William C. Reeves, MD.